(Q36133050)

12 August 2017

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders (English)

1 reference

12 August 2017

0 references

1 reference

2

Hervé Avet-Loiseau

0 references

Sonia Fabris

Sonia Fabris

8

0 references

Paolo Bernasconi

Paolo Bernasconi

16

0 references

Norma C. Gutiérrez

Norma C Gutiérrez

4

0 references

Zuzana Zemanová

Zuzana Zemanova

18

0 references

Mette Nyegaard

Mette Nyegaard

29

0 references

Kyra Michalová

Kyra Michalova

19

0 references

Hans Erik Johnsen

Hans E Johnsen

30

0 references

Pieter Sonneveld

28

Pieter Sonneveld

1 reference

12 August 2017

Fiona M Ross

1

1 reference

12 August 2017

Geneviève Ameye

3

1 reference

12 August 2017

Peter Liebisch

5

1 reference

12 August 2017

Sheila O'Connor

6

1 reference

12 August 2017

Klara Dalva

7

1 reference

12 August 2017

Adele M Testi

9

1 reference

12 August 2017

Marie Jarosova

10

1 reference

12 August 2017

Clare Hodkinson

11

1 reference

12 August 2017

Anna Collin

12

1 reference

12 August 2017

Gitte Kerndrup

13

1 reference

12 August 2017

Petr Kuglik

14

1 reference

12 August 2017

Dariusz Ladon

15

1 reference

12 August 2017

Brigitte Maes

17

1 reference

12 August 2017

Lucienne Michau

20

1 reference

12 August 2017

Kai Neben

21

1 reference

12 August 2017

N Emil U Hermansen

22

1 reference

12 August 2017

Katrina Rack

23

1 reference

12 August 2017

Alberto Rocci

24

1 reference

12 August 2017

Rebecca Protheroe

25

1 reference

12 August 2017

Laura Chiecchio

26

1 reference

12 August 2017

Hélène A Poirel

27

1 reference

12 August 2017

European Myeloma Network

31

1 reference

12 August 2017

27 February 2012

1 reference

12 August 2017

1 reference

12 August 2017

97

1 reference

12 August 2017

8

1 reference

12 August 2017

1272-1277

1 reference

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Role of genetics in prognostication in myeloma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Genetic events in the pathogenesis of multiple myeloma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Review of molecular diagnostics in multiple myeloma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Multicolor fluorescence in situ hybridization studies in multiple myeloma and monoclonal gammopathy of undetermined significance.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Multiple myeloma: evolving genetic events and host interactions

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Chromosome translocations in multiple myeloma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Multiple myeloma: increasing evidence for a multistep transformation process

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Genetics and cytogenetics of multiple myeloma: a workshop report

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myélome.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409827

Genomic abnormalities in monoclonal gammopathy of undetermined significance

5 December 2018

1 reference

12 December 2020

Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance

1 reference

12 December 2020

High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization

1 reference

12 December 2020

Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated

1 reference

12 December 2020

Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma

1 reference

12 December 2020

10.3324/HAEMATOL.2011.056176

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22371180

1 reference